Zai Lab announces approval of TIVDAK for patients with recurrent or metastatic cervical cancer in...

Health Canada approves ELAHERE for certain types of platinum resistant ovarian cancers

Avenzo Therapeutics announces FDA clearance of Investigational New Drug application for AVZO-103, a potential best-in-class...

Radiance Biopharma signs exclusive license for ‘first in class’ c-Met/EGFR targeted nano antibody ADC

OBI Pharma and AP Biosciences sign technology collaboration agreement to develop next-generation ADC

Twist Bioscience collaborates with Synthetic Design Lab